Category: CovidienSyndicate content

COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A

October 29, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien unveils next-gen superDimension device

October 27, 2014 by Brad Perriello

Covidien unveils the next generation of its superDimension device for lung imaging procedures.

Covidien unveils next-gen superDimension device

Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien says it plans to divest its some of its vascular therapies business to mollify U.S. anti-trust regulators about its proposed $43 billion merger with Medtronic.

Covidien plans to sell some vascular therapies ahead of Medtronic merger

Medtech's betting on the GOP in midterm elections

October 24, 2014 by Brian Johnson

A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.

Medtech's betting on the GOP in midterm elections

The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.

Medtronic updates on $43B Covidien deal financing

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

October 24, 2014 by Brian Johnson

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

Survey: Stroke still a mystery to many

October 23, 2014 by Alexander Soule

Despite stroke being the 2nd leading cause of death worldwide, many people still don't recognize risk factors and warning signs, according to a new poll sponsored by Covidien and the World Stroke Organization.

Survey: stroke still mystery to many

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp